Currently, the combination of one MUC-1 family protein (such as CA15-3, BR27.29, MCA, and CA549) and carcinoembryonic antigen (CEA) is the recommended serum marker panel in BC patients [3]. This evidence concerns the gene CEACAM5 and breast cancer.